This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Daegu Gyeongbuk Institute of Science and Technology, Samsung Electronics Co., Ltd.. Active years: 2016-2020.
Company Filing History:

Years Active: 2016-2020
Title: The Innovative Contributions of Euiseok Shin
Introduction
Euiseok Shin is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at improving health outcomes. With a total of 2 patents, his work reflects a commitment to advancing medical science.
Latest Patents
Shin's latest patents include a composition comprising farnesol and its use in increasing PGC-1α gene expression, decreasing PARIS gene expression, or promoting farnesylation of PARIS in mammalian cells. This method involves administering an effective amount of farnesol or its pharmaceutically acceptable salts to the cells. Another significant patent focuses on a composition for preventing or treating the side effects of steroids in subjects, which includes acetylsalicylic acid. This method aims to prevent or treat glucocorticoid side effects by administering acetylsalicylic acid or its acceptable forms.
Career Highlights
Throughout his career, Euiseok Shin has worked with esteemed organizations such as the Daegu Gyeongbuk Institute of Science and Technology and Samsung Electronics Co., Ltd. His experience in these institutions has allowed him to hone his skills and contribute to innovative research and development.
Collaborations
Shin has collaborated with notable colleagues, including Sungchun Cho and Sangchul Park. These partnerships have facilitated the exchange of ideas and fostered advancements in their respective fields.
Conclusion
Euiseok Shin's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the medical community positively.